Diaz-Otero, Janice M <br/><br/>
Mineralocorticoid receptor antagonism improves parenchymal arteriole dilation via a TRPV4-dependent mechanism and prevents cognitive dysfunction in hypertension.  [electronic resource] 

 -  American journal of physiology. Heart and circulatory physiology  11 2018 
 - H1304-H1315 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-1539 
<br/><br/><label>Standard No.: </label>10.1152/ajpheart.00207.2018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II<br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Arterioles--drug effects<br/>Behavior, Animal--drug effects<br/>Brain--blood supply<br/>Cognition--drug effects<br/>Cognition Disorders--etiology<br/>Disease Models, Animal<br/>Eplerenone--pharmacology<br/>Hypertension--chemically induced<br/>Male<br/>Maze Learning--drug effects<br/>Mice, Inbred C57BL<br/>Mineralocorticoid Receptor Antagonists--pharmacology<br/>Nesting Behavior--drug effects<br/>Recognition, Psychology--drug effects<br/>Signal Transduction--drug effects<br/>TRPV Cation Channels--antagonists & inhibitors<br/>Vasodilation--drug effects